Bone Marrow TransplantationTransplantation, AutologousBone Marrow PurgingBone MarrowCombined Modality TherapyTransplantation, HomologousCyclophosphamideBone Marrow CellsWhole-Body IrradiationCarmustineAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinMelphalanGraft vs Host DiseaseEtoposideHematopoietic Stem Cell TransplantationHodgkin DiseaseRemission InductionBusulfanTransplantation ConditioningCytarabineLeukemia, Myeloid, AcuteLeukemiaRecurrenceTreatment OutcomeHematopoietic Stem CellsColony-Forming Units AssayActuarial AnalysisLeukemia, MyeloidBone and BonesPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisBone Marrow DiseasesGraft SurvivalHematopoiesisPodophyllotoxinVincristineAnemia, AplasticDrug EvaluationSalvage TherapyDisease-Free SurvivalLymphomaThiotepaTime FactorsSurvival RateLiver TransplantationTransplantation ChimeraFollow-Up StudiesDoxorubicinTissue DonorsAcute DiseaseTransplantation, IsogeneicLeukocyte CountStem Cell TransplantationPrognosisGranulocyte Colony-Stimulating FactorHistocompatibility TestingMitoxantroneLymphatic IrradiationHistocompatibilityMultiple MyelomaMyelodysplastic SyndromesPrednisoneGranulocyte-Macrophage Colony-Stimulating FactorMesnaImmunosuppressionNeuroblastomaPlatelet CountAntibodies, MonoclonalProspective StudiesNeutropeniaBlood Cell CountLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRetrospective StudiesKidney TransplantationHepatic Veno-Occlusive DiseaseAntineoplastic AgentsOvarian Function TestsGonadal DisordersHematologic DiseasesGranulocytesT-LymphocytesCisplatinMethotrexateCyclosporineLomustineImmunosuppressive AgentsPrednimustineVindesineLymphoma, FollicularMice, Inbred C57BLDrug Administration ScheduleRicinRadiation ChimeraHematologic NeoplasmsBone Marrow ExaminationAgranulocytosisBleomycinNeoplasm, ResidualThrombocytopenia